National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search  E-Mail This Search
Clinical Trial Questions?
Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 90 for your search:
Cancer Type/Condition:  Leukemia, acute myeloid (AML), adult
Stage/Subtype:  untreated adult acute myeloid leukemia
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 30
Sponsor: NCI
Protocol IDs: COG-AAML0531, AAML0531, NCT00372593
2.
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0521, S0521, NCT00492856
3.
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 59
Sponsor: NCI
Protocol IDs: CALGB-10603, CALGB 10603, EUDRACT-2006-006852-37, NCT00651261
4.
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: S-WHITE-22304, 50047, S-WHITE-050047, NCT00397579
5.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NYCC-6898, 6898, NCI-6898, NCT00392353
6.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP4055-106, NCT00405743
7.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AT9283/0002, 2006-0177, NCT00522990
8.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 15 to 60
Sponsor: Other
Protocol IDs: 2006-0977, NCT00542971
9.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARRAY-520-211, NCT00637052
10.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 0702009008, VNP40101M, NCT00655395
11.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 0 to 55
Sponsor: Other
Protocol IDs: 8717, NCT00673114
12.
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 08-0172, NCT00691938
13.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: SU-04242009-2385, HEMAML0011, NCT00890929, RV-AML-0410, NCT00890929
14.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9090-04, NCT00964873
15.
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 265-103, NCT00975767
16.
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: NCI
Protocol IDs: CPMC-IRB-AAAA5571, CPMC-CAMP-016, NCI-G00-1891, NCT00008216
17.
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: Under 75
Sponsor: NCI
Protocol IDs: FHCRC-1898.00, 5788, NCT00089011
18.
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: FHCRC-1938.00, 5887, NCT00105001
19.
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E1905, E1905, NCT00313586
20.
Phase: Phase II
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: NCI
Protocol IDs: SWOG-S0605, S0605, NCT00352365
21.
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 15 to 59
Sponsor: NCI
Protocol IDs: CALGB-10503, NCT00416598
22.
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: JHOC-J0675, J0675, JHOC-NA_00003076, NCT00425477
23.
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2006-0706, NCT00413166
24.
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2006-0686, NCT00414310
25.
Phase: Phase II
Type: Treatment
Status: Active
Age: 15 to 75
Sponsor: Other
Protocol IDs: 2006-0813, NCT00422591
1     
New Search

Having trouble with this form? Check the help page or contact an NCI information specialist through LiveHelp online text chat or by calling 1-800-4-CANCER.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov